Replies to post #366491 on Amarin Corp Plc (AMRN)

[Whalatane]

Study. Thx for posting this info / analysis
Kiwi

[shadolane]

[Jasbg]

I do believe that big pharma was after it again and that they are working hard to diminish AMRN’s effects and ability to sell V in UK.

Think you are right there. A number of big trials in new CDV drugs on the way - they probably don't want a small company like Amarin to get to much attention.

https://www.cardiovascularbusiness.com/topics/prevention-risk-reduction/nhs-novartis-partner-save-30k-lives-new-drug

Even Vascepa (Vazkepa) - is a great drug - competition is always trying to 'steel your market share'.

So even there is no Generic competition in Europe - timing is is till everything - pointing to CBB's many post arguing for a BP takeover ASAP - to 'in the real world' - get this great drug to the hundred of thousands of CDV patients in Europe.

[couldbebetter]

Study, Thank you for posting. Your description justifies my belief
that AMRN must be in the hands of BP in order for Vascepa to be taken
seriously. (My guess here is that AZN/Dr. Nissan is behind McVeigh's
attack on Vazkepa.)

[dukesking]

Study, Good stuff. Thanks for sharing your insights.

[alm2]

Study
As a Uk citizen I am both astonished and appalled at the mum I jumbo rubbish that has been displayed by so called experts
Unbelievable that after all this time there is such ignorance and wilful blindness to the incredible benefits and cost effectiveness of this drug
No wonder there are so many Uk cvd deaths
God help us !!
Alm

[exwannabe]

Basically the fight is between AMRN saying $22,000 BP/QALY and ERG saying $88,000 BP/QALY

Translation: AMRN offered to sell at 173GBP/120 and NICE is countering to buy at 43GBP/120

Expect a compromise around 80-100GBP.